Influence of human granulocytemacrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells
Authors:
- Nedda K. HughesNHNedda K. Hughes
- 1 September 1995
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 57 (18) , PL265-PL273
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Influence of interleukin-3 (IL-3) on the hematopoietic toxicity associated with combination anti-viral drugs (zidovudine and DDI) in vitro using retrovirus-infected bone marrow cellsInternational Journal of Immunopharmacology, 1994
- Modulation of the haematopoietic toxicity associated with zidovudine in vivo with lithium carbonateJournal of Internal Medicine, 1993
- Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitroInternational Journal of Immunopharmacology, 1993
- Cytokine Stimulation of Multilineage Hematopoiesis from Immature Human Cells Engrafted in SCID MiceScience, 1992
- Comparison of the in vitro toxicity of 2′,3′‐dideoxynucleosides to murine hematopoietic progenitor cellsStem Cells, 1992
- Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudineThe American Journal of Medicine, 1991
- Hybrid cytokines as hematopoietic growth factorsStem Cells, 1991
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987